Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models Episkin™ and full thickness model from Episkin™

BACKGROUND Episkin and full thickness model from Episkin (FTM) are human skin models obtained from in vitro growth of keratinocytes into the five typical layers of the epidermis. FTM is a full thickness reconstructed skin model that also contains fibroblasts seeded in a collagen matrix. OBJECTIVES To assess whether enzymes involved in chemical detoxification are expressed in Episkin and FTM and how their levels compare with the human epidermis, dermis and total skin. METHODS Quantification of the mRNA expression levels of phases 1 and 2 metabolizing enzymes in cultured Episkin and FTM and human epidermis, dermis and total skin using Realtime PCR. RESULTS The data show that the expression profiles of 61 phases 1 and 2 metabolizing enzymes in Episkin, FTM and epidermis are generally similar, with some exceptions. Cytochrome P450-dependent enzymes and flavin monooxygenases are expressed at low levels, while phase 2 metabolizing enzymes are expressed at much higher levels, especially, glutathione-S-transferase P1 (GSTP1) catechol-O-methyl transferase (COMT), steroid sulfotransferase (SULT2B1b), and N-acetyl transferase (NAT5). The present study also identifies the presence of many enzymes involved in cholesterol, arachidonic acid, leukotriene, prostaglandin, eicosatrienoic acids, and vitamin D3 metabolisms. CONCLUSION The present data strongly suggest that Episkin and FTM represent reliable and valuable in vitro human skin models for studying the function of phases 1 and 2 metabolizing enzymes in xenobiotic metabolisms. They could be used to replace invasive methods or laboratory animals for skin experiments.

[1]  T Sakaki,et al.  Structure-function analysis of CYP27B1 and CYP27A1. Studies on mutants from patients with vitamin D-dependent rickets type I (VDDR-I) and cerebrotendinous xanthomatosis (CTX). , 2001, European journal of biochemistry.

[2]  J. Goldstein,et al.  Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension , 2005, Pharmacogenetics and genomics.

[3]  I. Phillips,et al.  Differential developmental and tissue-specific regulation of expression of the genes encoding three members of the flavin-containing monooxygenase family of man, FMO1, FMO3 and FM04. , 1996, European journal of biochemistry.

[4]  J. Lillehaug,et al.  Cloning and characterization of hNAT5/hSAN: An evolutionarily conserved component of the NatA protein N-α-acetyltransferase complex , 2006 .

[5]  H. Yamazaki,et al.  Mutagenic activation of 3-methoxy-4-aminoazobenzene by mouse renal cytochrome P450 CYP4B1: cloning and characterization of mouse CYP4B1. , 1995, Archives of biochemistry and biophysics.

[6]  S. Frankenberg,et al.  Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. , 2001, The Journal of investigative dermatology.

[7]  L. Marrot,et al.  Development of genotoxicity test procedures with Episkin, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds? , 2006, Mutation research.

[8]  R. Bradshaw,et al.  N-terminal processing: the methionine aminopeptidase and N alpha-acetyl transferase families. , 1998, Trends in biochemical sciences.

[9]  D. Bickers,et al.  Retinoid metabolism in the skin. , 1998, Pharmacological reviews.

[10]  K. von Figura,et al.  Genetic heterogeneity of steroid sulfatase deficiency revealed with cDNA for human steroid sulfatase. , 1987, Biochemical and biophysical research communications.

[11]  P. Botham,et al.  The validation of in vitro methods for skin irritation. , 2004, Toxicology letters.

[12]  Ralph A. Bradshaw,et al.  N-Terminal processing: the methionine aminopeptidase and Nα-acetyl transferase families , 1998 .

[13]  J. Meijer,et al.  Structural characterization of the human soluble epoxide hydrolase gene (EPHX2). , 1996, Biochemical and biophysical research communications.

[14]  A. Jalanko,et al.  Cloning and Characterization of Human Placental Catechol--Methyltransferase cDNA , 1991 .

[15]  J. Lillehaug,et al.  Expression of N-acetyl transferase human and human Arrest defective 1 proteins in thyroid neoplasms. , 2005, Thyroid : official journal of the American Thyroid Association.

[16]  P. Yen,et al.  Cloning and expression of steroid sulfatase cDNA and the frequent occurrence of deletions in STS deficiency: Implications for X-Y interchange , 1987, Cell.

[17]  F. Labrie,et al.  Quantitative appreciation of steroidogenic gene expression in mouse tissues: new roles for type 2 5α-reductase, 20α-hydroxysteroid dehydrogenase and estrogen sulfotransferase , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[18]  Zhengliang L. Wu,et al.  Structure and functions of human oxysterol 7alpha-hydroxylase cDNAs and gene CYP7B1. , 1999, Journal of lipid research.

[19]  V. Luu‐The,et al.  Characterization of a human 20alpha-hydroxysteroid dehydrogenase. , 2000, Journal of molecular endocrinology.

[20]  S. Creighton,et al.  Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolism. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Buolamwini,et al.  Molecular Cloning, Characterization, and Expression in Escherichia coli of Full-length cDNAs of Three Human Glutathione S-Transferase Pi Gene Variants , 1997, The Journal of Biological Chemistry.

[22]  J. S. Sidhu,et al.  Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. , 1994, Human molecular genetics.

[23]  R. Agarwal,et al.  Multiple cytochrome P450 isozymes in murine skin: induction of P450 1A, 2B, 2E, and 3A by dexamethasone. , 1994, The Journal of investigative dermatology.

[24]  S. Fukushima,et al.  Mutagenic activation of urinary bladder carcinogens by CYP4B1 and the presence of CYP4B1 in bladder mucosa. , 1997, Biochemical pharmacology.

[25]  D. Dinsdale,et al.  CYP4B1 activates 4-ipomeanol in rat lung. , 1993, Toxicology and applied pharmacology.

[26]  F Sherman,et al.  The Action of N-terminal Acetyltransferases on Yeast Ribosomal Proteins* , 1999, The Journal of Biological Chemistry.

[27]  J Kao,et al.  Cutaneous metabolism of xenobiotics. , 1990, Drug metabolism reviews.

[28]  K. Tomer,et al.  Molecular Cloning and Expression of CYP2J2, a Human Cytochrome P450 Arachidonic Acid Epoxygenase Highly Expressed in Heart (*) , 1996, The Journal of Biological Chemistry.

[29]  F. Labrie,et al.  Human Types 1 and 3 3α-Hydroxysteroid Dehydrogenases: Differential Lability and Tissue Distribution1 , 2001 .

[30]  E. Oliw,et al.  cDna cloning and expression of CYP4F12, a novel human cytochrome P450. , 2001, Biochemical and biophysical research communications.

[31]  D. Olde Weghuis,et al.  Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning and characterization of the coding sequence. , 1996, Biochemical and biophysical research communications.

[32]  J. Radomski,et al.  Bovine bladder mucosa microsomal cytochrome P-450 and 4-aminobiphenyl N-hydroxylase activity. , 1981, Cancer research.

[33]  D. Russell,et al.  Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. , 1991, The Journal of biological chemistry.

[34]  G. Nohynek,et al.  Under the skin: Biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human epidermis and human hepatocytes. , 2005, Toxicology letters.

[35]  J. Goldstein,et al.  Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. , 2001, Pharmacogenetics.

[36]  M. Sporn,et al.  Metabolism of all-trans-retinoic acid in hamster liver microsomes: oxidation of 4-hydroxy- to 4-keto-retinoic acid. , 1980, Archives of biochemistry and biophysics.

[37]  F. Guengerich.  Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. , 1988, Cancer research.

[38]  J. Thivolet,et al.  In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute. , 1991, Experimental cell research.

[39]  P. Soucy,et al.  Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase. , 1999, Endocrinology.

[40]  K. Palczewski,et al.  Pan1b (17βHSD11)-enzymatic activity and distribution in the lung , 2001, Molecular and Cellular Endocrinology.

[41]  B. Hammock,et al.  cDNA cloning and expression of a soluble epoxide hydrolase from human liver. , 1993, Archives of biochemistry and biophysics.

[42]  S. Povey,et al.  Cloning, primary sequence and chromosomal localization of human FMO2, a new member of the flavin-containing mono-oxygenase family. , 1992, The Biochemical journal.

[43]  B. Persson,et al.  Alcohol dehydrogenase 2 is a major hepatic enzyme for human retinol metabolism , 2007, Cellular and Molecular Life Sciences.

[44]  C. Hassett,et al.  The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. , 1994, Genomics.

[45]  H. Bolt,et al.  Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. , 1994, The Biochemical journal.

[46]  P. Bélanger,et al.  Steroid metabolism and profile of steroidogenic gene expression in Episkin™: High similarity with human epidermis , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[47]  D. Russell,et al.  Expression Cloning of an Oxysterol 7α-Hydroxylase Selective for 24-Hydroxycholesterol* , 2000, The Journal of Biological Chemistry.

[48]  C. Bradfield,et al.  Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[49]  F. Labrie,et al.  Human types 1 and 3 3 alpha-hydroxysteroid dehydrogenases: differential lability and tissue distribution. , 2001, Journal of Clinical Endocrinology and Metabolism.

[50]  Gillian Smith,et al.  Regulation of cutaneous drug‐metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo , 2006, The British journal of dermatology.

[51]  G. Ferron,et al.  Quantitation of cytochrome P450 mRNA levels in human skin. , 2003, Analytical biochemistry.

[52]  F. Labrie,et al.  Molecular Cloning of Human Type 3 3α-Hydroxysteroid Dehydrogenase That Differs from 20α-Hydroxysteroid Dehydrogenase by Seven Amino Acids , 1996 .

[53]  M. Ingelman-Sundberg,et al.  Identification of CYP4F8 in Human Seminal Vesicles as a Prominent 19-Hydroxylase of Prostaglandin Endoperoxides* , 2000, The Journal of Biological Chemistry.

[54]  S. Imaoka,et al.  A transgenic mouse expressing human CYP4B1 in the liver. , 2001, Biochemical and Biophysical Research Communications - BBRC.

[55]  Y. Fujii‐Kuriyama,et al.  Identification of a meander region proline residue critical for heme binding to cytochrome P450: implications for the catalytic function of human CYP4B1. , 1998, Biochemistry.

[56]  R. Duggleby,et al.  Analysis of the substrate specificity of human sulfotransferases SULT1A1 and SULT1A3: site-directed mutagenesis and kinetic studies. , 1999, Biochemistry.

[57]  D. Schadendorf,et al.  SEREX identification of new tumour‐associated antigens in cutaneous T‐cell lymphoma , 2004, The British journal of dermatology.

[58]  Y. Takahashi,et al.  A basis for differentiating among the multiple human Mu-glutathione S-transferases and molecular cloning of brain GSTM5. , 1993, The Journal of biological chemistry.

[59]  Flamand Nicole,et al.  再構築ヒト皮膚モデル,Episkinによる遺伝毒性試験手順の開発:経皮適用化合物のin vitroでの危険性評価のための新しいツールか? , 2006 .

[60]  E. Eichler,et al.  Human hydroxysteroid sulfotransferase SULT2B1: two enzymes encoded by a single chromosome 19 gene. , 1998, Genomics.

[61]  Jean Cumps,et al.  Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. , 2005, BioTechniques.

[62]  Mauro Santos,et al.  Genetic polymorphism of alcohol dehydrogenase in europeans: TheADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1 , 2000, Hepatology.

[63]  N. Javitt,et al.  Mutational Analysis of Human Hydroxysteroid Sulfotransferase SULT2B1 Isoforms Reveals That Exon 1B of the SULT2B1 Gene Produces Cholesterol Sulfotransferase, whereas Exon 1A Yields Pregnenolone Sulfotransferase* , 2002, The Journal of Biological Chemistry.

[64]  J. Warrington,et al.  Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes. , 2000, Physiological genomics.

[65]  K. Palczewski,et al.  Pan1b (17betaHSD11)-enzymatic activity and distribution in the lung. , 2001, Molecular and cellular endocrinology.

[66]  K. S. Kim,et al.  Novel homozygous and compound heterozygous mutations of sterol 27-hydroxylase gene (CYP27) cause cerebrotendinous xanthomatosis in three Japanese patients from two unrelated families. , 1997, Journal of lipid research.

[67]  B. Allen-Hoffmann,et al.  Cytochrome P450IA1 is rapidly induced in normal human keratinocytes in the absence of xenobiotics. , 1994, The Journal of biological chemistry.

[68]  V. Luu‐The,et al.  Characterization of a human 20-hydroxysteroid dehydrogenase , 2000 .

[69]  R. Weinshilboum,et al.  Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. , 1997, Biochemical and biophysical research communications.

[70]  D. van der A,et al.  Structural organization of the human short-chain L-3-hydroxyacyl-CoA dehydrogenase gene , 1998, Mammalian Genome.

[71]  T. Eling,et al.  The cytochrome P-450 monooxygenase system of rabbit bladder mucosa: enzyme components and isozyme 5-dependent metabolism of 2-aminofluorene. , 1985, Cancer research.